Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q2731762> ?p ?o }
Showing triples 1 to 51 of
51
with 100 triples per page.
- Q2731762 subject Q8493014.
- Q2731762 subject Q8504280.
- Q2731762 abstract "Teicoplanin is an antibiotic used in the prophylaxis and treatment of serious infections caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus and Enterococcus faecalis. It is a semisynthetic glycopeptide antibiotic with a spectrum of activity similar to vancomycin. Its mechanism of action is to inhibit bacterial cell wall synthesis.Teicoplanin is marketed by Sanofi-Aventis under the trade name Targocid. Other trade names include Ticosin marketed by Cipla(India).Oral teicoplanin has been demonstrated to be effective in the treatment of pseudomembranous colitis and Clostridium difficile-associated diarrhoea, with comparable efficacy with vancomycin.Its strength is considered to be due to the length of the hydrocarbon chain.".
- Q2731762 atcPrefix "J01".
- Q2731762 atcSuffix "XA02".
- Q2731762 bioavailability "90.0".
- Q2731762 casNumber "61036-62-2".
- Q2731762 drugbank "DB06149".
- Q2731762 fdaUniiCode "4U3D3YY81M".
- Q2731762 iupacName "Ristomycin A 34-O-[2-(acetylamino)-2-deoxy-.beta.-D-glucopyranosyl]-22,31-dichloro-7-demethyl-64-O-demethyl-19-deoxy-56-O-[2-deoxy-2-[(8-methyl-1-oxononyl)amino]-.beta.-D-glucopyranosyl]-42-O-.alpha.-D-mannopyranosyl-".
- Q2731762 pubchem "16129712".
- Q2731762 thumbnail Teicoplanin_core_and_major_components.svg?width=300.
- Q2731762 wikiPageWikiLink Q10876.
- Q2731762 wikiPageWikiLink Q11358.
- Q2731762 wikiPageWikiLink Q12187.
- Q2731762 wikiPageWikiLink Q140014.
- Q2731762 wikiPageWikiLink Q158205.
- Q2731762 wikiPageWikiLink Q1773974.
- Q2731762 wikiPageWikiLink Q2293474.
- Q2731762 wikiPageWikiLink Q23005640.
- Q2731762 wikiPageWikiLink Q284367.
- Q2731762 wikiPageWikiLink Q327506.
- Q2731762 wikiPageWikiLink Q335208.
- Q2731762 wikiPageWikiLink Q419178.
- Q2731762 wikiPageWikiLink Q424027.
- Q2731762 wikiPageWikiLink Q432083.
- Q2731762 wikiPageWikiLink Q574905.
- Q2731762 wikiPageWikiLink Q595158.
- Q2731762 wikiPageWikiLink Q640448.
- Q2731762 wikiPageWikiLink Q757764.
- Q2731762 wikiPageWikiLink Q8493014.
- Q2731762 wikiPageWikiLink Q8504280.
- Q2731762 wikiPageWikiLink Q857288.
- Q2731762 wikiPageWikiLink Q899689.
- Q2731762 wikiPageWikiLink Q9377.
- Q2731762 atcPrefix "J01".
- Q2731762 atcSuffix "XA02".
- Q2731762 bioavailability "90.0".
- Q2731762 casNumber "61036".
- Q2731762 drugbank "DB06149".
- Q2731762 iupacName "Ristomycin A 34-O-[2--2-deoxy-.beta.-D-glucopyranosyl]-22,31-dichloro-7-demethyl-64-O-demethyl-19-deoxy-56-O-[2-deoxy-2-[amino]-.beta.-D-glucopyranosyl]-42-O-.alpha.-D-mannopyranosyl-".
- Q2731762 pubchem "16129712".
- Q2731762 unii "4".
- Q2731762 type ChemicalSubstance.
- Q2731762 type Drug.
- Q2731762 type ChemicalObject.
- Q2731762 type Thing.
- Q2731762 type Q8386.
- Q2731762 comment "Teicoplanin is an antibiotic used in the prophylaxis and treatment of serious infections caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus and Enterococcus faecalis. It is a semisynthetic glycopeptide antibiotic with a spectrum of activity similar to vancomycin. Its mechanism of action is to inhibit bacterial cell wall synthesis.Teicoplanin is marketed by Sanofi-Aventis under the trade name Targocid.".
- Q2731762 label "Teicoplanin".
- Q2731762 depiction Teicoplanin_core_and_major_components.svg.
